目前市盈率19.4,市盈率TTM17.4,缺乏增长...查看全文
任我行19802016-09-22 11:18
$TARO PHARMACEUTICAL INDS LTD(TARO)$ 从事处方药与非处方药的开发、制造与销售,产品包括药膏、软膏、液体及片剂药物,还涉及活性药物成分的生产与销售,用于皮肤病、心血管与中枢神经系统治疗。查看全文
暴虐的高理歌2014-02-18 14:41
折腾了半天结果手上最赚钱的居然是随便买的$TARO PHARMACEUTICAL INDS LTD(TARO)$ 越来越觉得mkt efficiency充足的时候,跟着randomness和vol skew走才是真正的无招胜有招,决定重新做回完全的option trading,让breakouts和momentum见鬼去吧![能力圈]查看全文
$Taro Pharmaceutical(TARO)$ SC 13E3/A [Amend] Going private transaction by certain issuers Accession Number: 0001193125-24-095448 Act: 34 Size: 2 MB 网页链接
$Taro Pharmaceutical(TARO)$ SC 13E3/A [Amend] Going private transaction by certain issuers Accession Number: 0001193125-24-072749 Act: 34 Size: 1 MB 网页链接
$Taro Pharmaceutical(TARO)$ SC 13E3/A [Amend] Going private transaction by certain issuers Accession Number: 0001193125-24-064267 Act: 34 Size: 1 MB 网页链接
$Taro Pharmaceutical(TARO)$ SC 13E3 Going private transaction by certain issuers Accession Number: 0001193125-24-037103 Act: 34 Size: 19 MB 网页链接
$Taro Pharmaceutical(TARO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950170-24-007713 Act: 34 Size: 328 KB 网页链接
$Taro Pharmaceutical(TARO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950103-24-000737 Act: 34 Size: 301 KB 网页链接
$Taro Pharmaceutical(TARO)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0000950103-24-000736 Act: 34 Size: 412 KB 网页链接
$Taro Pharmaceutical(TARO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950170-24-001909 Act: 34 Size: 23 KB 网页链接
$Taro Pharmaceutical(TARO)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950103-23-017376 Act: 34 Size: 13 KB 网页链接
$Taro Pharmaceutical(TARO)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0000950103-23-017375 Act: 34 Size: 129 KB 网页链接